STOCKHOLM, March 28, 2018 /PRNewswire/ -- InDex Pharmaceuticals Holding AB (publ) today announced that a new method of use patent for the drug candidate cobitolimod will be issued by the Japan Patent Office. The patent provides additional protection for treating chronic active...
from PR Newswire: //https://ift.tt/2Gzsvln
No comments:
Post a Comment